Abstract Details

Title Alemtuzumab Positively Affects Disability Outcomes Using a One-Year-Sustained Criterion for Relapsing-Remitting Multiple Sclerosis Patients in CAMMS223

Topic MS and Related Diseases

Presentation(s) (-)

Poster/Presentation
Number 216

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Mark C. Cascione, MD (Tampa Neurology Associates)	No disclosure on file
	No disclosure on file
Frank Tennigkeit, PhD (UCB Biosciences GmbH)	Dr. Tennigkeit has received personal compensation for serving as an employee of UCB Biosciences. Dr. Tennigkeit has stock in UCB Biosciences.
Michelle Whaley (Swedish Medical Center)	No disclosure on file

��ɫ��

��ɫ��

Abstract Details

��ɫ����

��ɫ����

��ɫ��

��ɫ��